March 27, 2020 | Mohammad Sajadi and Anthony Amoroso, MD
Source:
The Washington Post
www.washingtonpost.com
By: Mohammad Sajadi and Anthony Amoroso, MD
Mohammad Sajadi, MD and Anthony Amoroso, MD are associate professors of medicine at the Institute of Human Virology at the University of Maryland School of Medicine and members of the Global Virus Network.
As physicians and researchers, we have spoken to doctors across the country over the past few weeks and kept hearing variations on this description of the novel coronavirus’s spread: It’s like a chemical bomb went off. One day everything seemed normal, and the next everyone became sick: patients, nurses, family members.
The pattern is scary, but familiar. Seasonal respiratory viruses, most infamously influenza, can act in the same explosive fashion. In temperate areas, every fall and winter, as the weather cools and humidity drops, influenza ferociously takes hold and retains a strong grip until spring. There are four coronaviruses — viruses that are common in humans, usually causing moderate respiratory illnesses — that are also seasonal.
Read the full story at: https://www.washingtonpost.com/opinions/2020/03/27/covid-19-is-probably-seasonal-thats-no-reason-relax/
Contact
Institute of Human Virology
Jennifer Gonzales
Public Relations & Communications Manager
jennifer.gonzales@ihv.umaryland.edu
Related stories
Wednesday, March 20, 2024
New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections & Vaccines
Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.
Monday, April 25, 2022
Institute of Human Virology’s Mohammad Sajadi Elected to American Society for Clinical Investigation
The American Society for Clinical Investigation (ASCI) elected Mohammad Sajadi, MD, Professor of Medicine in the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) as a 2022 member.
Friday, January 28, 2022
The Washington Post: COVID-19 may have seasons for different temperature zones, study suggests
COVID-19 transmission may have seasonal spikes tied to temperature and humidity, increasing at different times of the year for different locations, a new study in the American Journal of Tropical Medicine and Hygiene suggests.
Tuesday, November 02, 2021
CNN: Johnson & Johnson's Covid-19 vaccine is 73.6% effective, according to new real-world study
In an accompanying commentary, Dr. Mohammad Sajadi of the Institute of Human Virology at the University of Maryland School of Medicine, argued that the findings are part of a growing body of work that suggests "room for improvement" with the J&J vaccine.
Friday, January 22, 2021
Getting treatment early for COVID-19
Baltimore (WBFF) — If you test positive for COVID-19, doctors are reminding you to get treatment right away even if your symptoms aren't bad in the moment. Dr. Anthony Amoroso, infectious disease specialist at the University of Maryland School of Medicine, joins the morning show to talk about why that's important.
Monday, October 12, 2020
WJLA (Washington, DC): How long can you spread coronavirus once infected? We found out.
Social distancing, hand hygiene and face masks can help curb the spread of the highly contagious coronavirus but if you do get sick, how long can you spread COVID to others? 7 On Your Side went looking for answers.
Monday, September 28, 2020
Associated Press: 500 years ago, another epidemic swept Mexico: smallpox
There were mass cremations of bodies; entire families died and the inhabitants of the city, afraid to pull their bodies out, simply collapsed their homes on top of them to bury them on the spot. The scene, beyond even the current coronavirus pandemic, was a scourge brought 500 years ago by Spanish conquistadores and their servants that exploded in Mexico City in September 1520. Smallpox and other newly introduced diseases went on to kill tens of millions of Indigenous people in the Americas who had no resistance to the European illnesses. The viruses later spread to South America, and helped lead to the downfall and overthrow of empires like the Aztecs and Incas. And its lessons remain largely forgotten today.
Tuesday, June 02, 2020
UM School of Medicine’s Institute of Human Virology Awarded Grants to Strengthen COVID-19 Response in Sub-Saharan Africa
The Center for International Health, Education and Biosecurity (Ciheb) at the University of Maryland School of Medicine’s Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention (CDC) to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique.
Monday, May 11, 2020
BBC Global News Interviews Dr. Robert Gallo on Oral Polio Vaccine for SARS-CoV-2 and More
Dr. Robert Gallo appeared on BBC World News with Matthew Amroliwala for a one-on-one, lengthy interview during their Coronavirus Explained segment.
Wednesday, April 29, 2020
Dr. Robert Gallo Appears on C-SPAN’s Washington Journal
Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.
Monday, April 27, 2020
Expert Breaks Down Coronavirus Research: Is it Worse than HIV? Is it Mutating?
IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.
Wednesday, April 22, 2020
Dr. Robert Gallo on India Today Discussing the Oral Polio Vaccine for COVID-19
IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep
Friday, April 17, 2020
Dr. Robert Gallo Discusses Repurposing the Oral Polio Vaccine on CNN
Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.
Monday, April 13, 2020
Can an Oral Polio Vaccine Stop COVID-19?
Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).
Wednesday, April 08, 2020
Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV
Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
Tuesday, April 07, 2020
A Deep Look Into The Coronavirus with Dr. Robert Gallo on WYPR (Baltimore’s local NPR station)
(WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.
Wednesday, April 01, 2020
Dr. Robert Gallo Featured on MSNBC’s 11th Hour with Brian Williams
Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.
Thursday, February 06, 2020
IHV Joins Global Virus Network (GVN) Discussions with International Top Experts to Combat Growing Novel Coronavirus Epidemic
The GVN, with support from the IHV, Is Bridging Gaps in the Global Emergency Response and Serving as a “Go-To” Resource for Members Needing Assistance in Obtaining and Disseminating Cutting-Edge Scientific Research.